Part 2 in the webinar series, this presentation provides information on the Rhode Island Health Equity Zone experience and discusses how other OD2A-funded jurisdictions can infuse critical social determinants of health-related priorities in their overdose prevention and surveillance efforts.Read More »
This presentation by Nancy Byatt, DO, MS, MBA, FACLP, describes MCPAP for Moms, a Massachusetts program that provides consultation to health care providers for behavioral health concerns and questions around medications when pregnant or breastfeeding, and connects people to community-based services and support groups.Read More »
This webinar features Dr. Rachel Wightman, cofounder of the Buprenorphine Hotline in Rhode Island, and Dr. Gwen Latendresse from the University of Utah’s Telehealth Pilot Project for pregnant and postpartum women. They describe their work, the federal policy changes that enabled the development of their telehealth models of care, and offer lessons learned and goals for future growth of tele-mental health and substance use programs.Read More »
This webinar highlights the use of the Overdose Detection Mapping Application Program (ODMAP), a syndromic surveillance application that serves as a collaborative and centralized platform for all disciplines responding to the crisis. In this recorded webinar, Aliese Alter, Senior Program Manager, and Christopher Yeager, ODMAP Data and Research Analyst, share an overview of the ODMAP tool and discuss trends in overdose data since the start of the COVID-19 outbreak in U.S. as well as methods for examining these trends.Read More »
In this webinar, Sheila Vakharia (Deputy Director, Drug Policy Alliance) discusses national trends in stimulant use data and shares harm reduction strategies for stimulants. Speakers - Katie Bee (Iowa Dept. of Health), and Michelle Tilotta (Iowa Dept. of Health), on the other hand, describe Iowa strategic efforts in addressing the impacts of methamphetamine through a public health lens.Read More »
The Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative (OMNI) Learning Community hosted its second ASTHOConnect of Year Two highlighting how primary care providers can be a part of the care team for pregnant/postpartum women and infants experiencing substance use disorder. It featured a presentation from HRSA to provide the federal perspective on engaging primary care associations and leveraging federally qualified health centers for OMNI related work. It also featured two FQHCs on their role providing services to pregnant and postpartum women affected by opioid use disorder and infants prenatally exposed to substances.Read More »
The fourth virtual learning session for the PRISM Learning Community was on the use of telehealth to improve access to substance use disorder treatment, including medically assisted treatment, in maternal and child populations.Read More »
The third virtual learning session of the PRISM Learning Community discusses current research and treatment recommendations on the use of medication-assisted treatment (MAT) during pregnancy, state policy considerations on the issue, and opportunities for Title V programs to support MAT efforts in states.Read More »
The Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative (OMNI) Learning Community’s first ASTHOConnect of Year Two will highlight two examples of successful models for integrating maternal care and substance use treatment. Elisabeth Johnson from UNC Horizons and Dr. Lorraine Milio from Johns Hopkins’ Center for Addiction and Pregnancy will provide overviews of their organizations, discuss the successes and challenges faced by their programs, and provide recommendations for states interested in integrating care. ASTHO will also discuss Learning Community updates including teams’ state action plans, TA opportunities, and a new resource for peer-to-peer sharing between states.Read More »
The second virtual learning session of the PRISM Learning Community discusses maternal mental health systems change, and how states can use Medicaid Institutions of Mental Diseases (IMD) waivers to improve access to care for pregnant and parenting women with substance use disorder.Read More »
The Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative (OMNI) Learning Community’s fourth ASTHOConnects webinar provides a wrap up of OMNI’s first year and a discussion on how the learning community will expand in Year Two. This webinar also features a presentation from Virginia Commonwealth University’s Mishka Terplan, who discusses the importance of how stigma, language, and a focus on the mother/baby dyad influences policy and impacts women, children, and families with substance use disorder.Read More »
The first virtual learning session of the PRISM Learning Community discusses the logistical, legislative, and legal issues around universal testing/screening for substance use in pregnant and parenting women and their newborns.Read More »
The third webinar from the OMNI Learning Community highlights neonatal abstinence syndrome (NAS) and how using a statewide, multidisciplinary approach to NAS can address several levels of intervention.Read More »
This webinar shares insights from state officials to address the needs of people living with or at risk of developing SUD and features state examples of successful partnerships in action.Read More »
This webinar highlights how New York and Tennessee are using the ACEs behavioral risk factor surveillance system module to inform their program work in early brain development and substance misuse.Read More »
The Opioid Use Disorder, Maternal Outcomes, and
Neonatal Abstinence Syndrome Initiative (OMNI) Learning Community’s second
ASTHOConnects discusses the development of Plans of Safe Care to improve
outcomes for families and infants born with substance exposure. This webinar
features presentations from Kentucky and Rhode Island who discussed their
states' development and implementation of a Plan of Safe Care process.Read More »
ASTHO and CDC hosted an ASTHOConnects on evidence-based practices that prevent infectious disease consequences related to the opioid epidemic. CDC, Vermont state and local representatives shared
their perspectives on policy levers and partnerships for implementing syringe services programs (SSPs) and building linkages to treatment for substance misuse.Read More »
This webinar highlights the AIM patient safety bundle – Obstetric Care for Women with Opioid Use Disorder – and state and national efforts and strategies for addressing substance use disorders, including opioid use and misuse, among women of childbearing age and during pregnancy.Read More »